← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2014Last known activity
Sep 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 9 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT07300488Lead sponsorPhase 2/Phase 3Sep 1, 2025
- NCT07203118Lead sponsorPhase 2/Phase 3Jul 1, 2025
- NCT06280534Lead sponsorPhase 1Jul 18, 2023
- NCT06122454Lead sponsorPhase 1/Phase 2Nov 10, 2022
- NCT06141109Lead sponsorPhase 1/Phase 2Jan 18, 2022
- NCT04543565Lead sponsorPhase 3Sep 30, 2020
- NCT04277897Lead sponsorPhase 1Mar 15, 2020
- NCT06141096Lead sponsorPhase 2Jan 17, 2020
- NCT02623569Lead sponsorPhase 2Oct 1, 2014
Details
- Last known activity
- Sep 1, 2025